Dr Reddy's Laboratories Ltd (RDDA STU) stock market data APIs
€11.8721
0.24(2.1%)
as of March 13, 2025
Dr Reddy's Laboratories Ltd Financial Data Overview
Prev. Close
11.6367
Open
11.8721
High
11.8721
Low
11.2806
52 wk Range
11.3-15.4
Market Cap
8 926 M
Dividends (Yield)
0.0056
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get Dr Reddy's Laboratories Ltd data using free add-ons & libraries
Get Dr Reddy's Laboratories Ltd Fundamental Data
Dr Reddy's Laboratories Ltd Fundamental data includes:
- Net Revenue:
- EBITDA:
- Earnings Per Share: 0
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: NaN
- EPS/Forecast: NaN
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Dr Reddy's Laboratories Ltd News
New
Dr. Reddy’s enters into collaboration with Henlius for commercialization of HLX15 (daratumumab), a biosimilar candidate to Darzalex® & Darzalex Faspro® in the U.S., and Europe
Dr. Reddy’s gets exclusive rights to commercialize the subcutaneous as well as intravenous formulations of HLX15 in the U.S. and Europe HYDERABAD, India, February 06, 2025--(BUSINESS WIRE)--Dr. Red...
Henlius and Dr. Reddy's Ink Licensing Deal for HLX15 (investigational daratumumab biosimilar) Expansion in Europe and the U.S.
SHANGHAI, Feb. 6, 2025 /PRNewswire/ -- Shanghai Henlius Biotech, Inc. (2696.HK) today announced it has entered into a license agreement with Dr. Reddy's Laboratories SA, wholly-owned subsidiary of D...
Dr. Reddy’s Q3 & 9MFY25 Financial Results
HYDERABAD, India, January 23, 2025--(BUSINESS WIRE)--Dr. Reddy’s Laboratories Ltd. (BSE: 500124 | NSE: DRREDDY | NYSE: RDY | NSEIFSC: DRREDDY) today announced its consolidated financial results for ...
Dr. Reddy’s Laboratories Allocates Equity Shares to Employees
https://www.tipranks.com/news/the-fly/alterity-ceo-says-filled-with-optimism-for-2025 Dr Reddy’s Laboratories ( (RDY) ) has provided an update. Don't Miss Our Christmas Offers: Discover the lates...
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
- Price stability: Locked-in rates for subscribed users, never changing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
